Development and optimization of a tamsulosin nanostructured lipid carrier loaded with saw palmetto oil and pumpkin seed oil for treatment of benign prostatic hyperplasia

• Ngā kaituhi matua: Rana B. Bakhaidar (Author), Khaled M. Hosny (Author), Imman M. Mahier (Author), Waleed Y. Rizq (Author), Awaji Y. Safhi (Author), Deena M. Bukhary (Author), Muhammad H. Sultan (Author), Haitham A. Bukhary (Author), Osama A. Madkhali (Author), Fahad Y. Sabei (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Benign prostatic hyperplasia (BPH) is a nonmalignant growth of the prostate tissue and causes urinary tract symptoms. To provide effective treatment, tamsulosin (TM), saw palmetto oil (SP), and pumpkin seed oil (PSO) were combined and fabricated a nanostructured lipid carrier (NLC) as TM-S/P-NLC usi...